Beth Stevens, PhD

Boston Children's Hospital · company speakers →

Emerging genetic studies implicate microglia in Alzheimer’s disease and other brain diseases, yet it's unclear how they contribute to cognitive dysfunction. Microglia eliminate synaptic connections using molecules from the innate immune system, shedding light on mechanisms of pathological synapse loss. This session will outline paths to define microglia-mediated disease mechanisms, highlighting new models and approaches that bridge gaps between genetics, cellular states, and function.

healthcare-servicespharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Neuroscience

13 November 2027 Chicago, United States “Bridging Genes and Biology: Exploring Neuroimmune Mechanisms Behind Synapse Loss and Dysfunction”

Neuroscience

14 November 2026 Washington, United States “Bridging Genes and Biology: Exploring Neuroimmune Mechanisms Behind Synapse Loss and Dysfunction”

Topics this speaker covers

healthcare-servicespharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →